AGP Executive Report
Last update: 5 hours agoMedicare Access Friction: A new U.S. review finds Medicare Advantage prior authorizations are denying skilled nursing facility requests at a 12% overall rate, with big insurer-to-insurer swings—highlighting how “coverage” can still mean “no rehab.” Obesity Drug Guidance: The American College of Physicians updates obesity care, putting high-efficacy GLP-1s like semaglutide and tirzepatide as first-line options for many adults with BMI ≥30. Drug Pricing Pressure in Europe: Reuters reports big pharma is using threats to slow investment and launches to push back on tighter European drug-price rules, with Germany now in the crosshairs after Britain’s deal. Ebola Support: India pledges $10 million for Ebola preparedness and response via an African Union virtual summit, alongside earlier medical supply deliveries. Medical Cannabis Trade: High Tide’s German subsidiary Remexian showcases exclusive Canadian medical cannabis brand partnerships at Mary Jane Berlin 2026. Patient Safety & Care Gaps: A Glasgow ambulance crash left a patient dying after a “medical matter,” while two paramedics and a student paramedic were injured. Clinical Research Signal: A study finds molecular differences in pregnant people’s blood that may help predict early vs pre-term birth risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
